Morbimortality after 1321 consecutive CRS + HIPEC procedures: seeking excellence in surgery for peritoneal surface malignancy.

Maria Isabel Ramos Bernadó Oriol Crusellas Montserrat Martín-Baranera Pedro Barrios

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)

Implementation of a CRS + HIPEC referral program for the treatment of PSM with preferably an experienced surgical team enables acceptable rates of severe morbidity (20%) and mortality (< 1%).

Keyphrases

quality improvement
primary care
minimally invasive
healthcare
palliative care
mental health
early onset
combination therapy
replacement therapy
surgical site infection
acute coronary syndrome
drug induced